메뉴 건너뛰기




Volumn 29, Issue 6, 2013, Pages 971-978

Rapid, quantitative mapping of anti-HIV type 1 envelope serum antibody specificities

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEUTRALIZING ANTIBODY; PRIMER DNA; VIRUS VACCINE; VIRUS VECTOR;

EID: 84877866082     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0317     Document Type: Article
Times cited : (1)

References (19)
  • 2
    • 80052925616 scopus 로고    scopus 로고
    • Sequence and structural convergence of broad and potent hiv antibodies that mimic cd4 binding
    • Scheid JF, Mouquet H, Ueberheide B, et al.: Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 2011;333(6049):1633-1637
    • (2011) Science , vol.333 , Issue.6049 , pp. 1633-1637
    • Scheid, J.F.1    Mouquet, H.2    Ueberheide, B.3
  • 3
    • 80053132436 scopus 로고    scopus 로고
    • Broad neutralization coverage of hiv by multiple highly potent antibodies
    • Walker LM, Huber M, Doores KJ, et al.: Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 2011;477(7365):466-470
    • (2011) Nature , vol.477 , Issue.7365 , pp. 466-470
    • Walker, L.M.1    Huber, M.2    Doores, K.J.3
  • 4
    • 70349887757 scopus 로고    scopus 로고
    • Broad and potent neutralizing antibodies from an african donor reveal a new hiv-1 vaccine target
    • Walker LM, Phogat SK, Chan-Hui PY, et al.: Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 2009;326(5950): 285-289
    • (2009) Science , vol.326 , Issue.5950 , pp. 285-289
    • Walker, L.M.1    Phogat, S.K.2    Chan-Hui, P.Y.3
  • 5
    • 77958115264 scopus 로고    scopus 로고
    • A limited number of antibody specificities mediate broad and potent serum neutralization in selected hiv-1 infected individuals
    • Walker LM, Simek MD, Priddy F, et al.: A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals. PLoS Pathog 2010;6(8):e1001028
    • (2010) PLoS Pathog , vol.6 , Issue.8
    • Walker, L.M.1    Simek, M.D.2    Priddy, F.3
  • 6
    • 84863269120 scopus 로고    scopus 로고
    • HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopes
    • Doria-Rose NA, Louder MK, Yang Z, et al.: HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopes. J Virol 2012;86(6): 3393-3397
    • (2012) J Virol , vol.86 , Issue.6 , pp. 3393-3397
    • Doria-Rose, N.A.1    Louder, M.K.2    Yang, Z.3
  • 7
    • 80052495503 scopus 로고    scopus 로고
    • Multiplex measurement of proinflammatory cytokines in human serum: Comparison of the meso scale discovery electrochemiluminescence assay and the cytometric bead array
    • Dabitao D, Margolick JB, Lopez J, and Bream JH: Multiplex measurement of proinflammatory cytokines in human serum: Comparison of the Meso Scale Discovery electrochemiluminescence assay and the Cytometric Bead Array. J Immunol Methods 2011;372(1-2):71-77
    • (2011) J Immunol Methods , vol.372 , Issue.1-2 , pp. 71-77
    • Dabitao, D.1    Margolick, J.B.2    Lopez, J.3    Bream, J.H.4
  • 8
    • 84877350114 scopus 로고    scopus 로고
    • Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting 3 distinct epitopes
    • in press
    • Hoffenberg S, Powell R, Carpov A, et al.: Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting 3 distinct epitopes. J Virol 2013 (in press
    • (2013) J Virol
    • Hoffenberg, S.1    Powell, R.2    Carpov, A.3
  • 9
    • 0033819031 scopus 로고    scopus 로고
    • Biotinylation of proteins in vivo and in vitro using small peptide tags
    • Cull MG and Schatz PJ: Biotinylation of proteins in vivo and in vitro using small peptide tags. Methods Enzymol 2000;326: 430-440
    • (2000) Methods Enzymol , vol.326 , pp. 430-440
    • Cull, M.G.1    Schatz, P.J.2
  • 10
    • 78650633879 scopus 로고    scopus 로고
    • The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter
    • Lynch RM, Rong R, Boliar S, et al.: The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter. J Virol 2011; 85(2):905-915
    • (2011) J Virol , vol.85 , Issue.2 , pp. 905-915
    • Lynch, R.M.1    Rong, R.2    Boliar, S.3
  • 11
    • 0028027741 scopus 로고
    • Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1
    • Gorny MK, Moore JP, Conley AJ, et al.: Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1. J Virol 1994;68(12):8312-8320
    • (1994) J Virol , vol.68 , Issue.12 , pp. 8312-8320
    • Gorny, M.K.1    Moore, J.P.2    Conley, A.J.3
  • 12
    • 0038618737 scopus 로고    scopus 로고
    • A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit th-e epitope of the broadly neutralizing antibody immunoglobulin G1 b12
    • Zwick MB, Kelleher R, Jensen R, et al.: A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12. J Virol 2003;77(12):6965-6978
    • (2003) J Virol , vol.77 , Issue.12 , pp. 6965-6978
    • Zwick, M.B.1    Kelleher, R.2    Jensen, R.3
  • 13
    • 4143088167 scopus 로고    scopus 로고
    • Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody
    • Zhang MY, Xiao X, Sidorov IA, et al.: Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody. J Virol 2004;78(17):9233-9242
    • (2004) J Virol , vol.78 , Issue.17 , pp. 9233-9242
    • Zhang, M.Y.1    Xiao, X.2    Sidorov, I.A.3
  • 14
    • 80054988972 scopus 로고    scopus 로고
    • Characterization of structural features and diversity of variable-region determinants of related quaternary epitopes recognized by human and rhesus macaque monoclonal antibodies possessing unusually potent neutralizing activities
    • Krachmarov C, Lai Z, Honnen WJ, et al.: Characterization of structural features and diversity of variable-region determinants of related quaternary epitopes recognized by human and rhesus macaque monoclonal antibodies possessing unusually potent neutralizing activities. J Virol 2011;85(20): 10730-10740
    • (2011) J Virol , vol.85 , Issue.20 , pp. 10730-10740
    • Krachmarov, C.1    Lai, Z.2    Honnen, W.J.3
  • 15
    • 77955657135 scopus 로고    scopus 로고
    • Structure-guided design and immunological characterization of immunogens presenting the hiv-1 gp120 v3 loop on a ctb scaffold
    • Totrov M, Jiang X, Kong XP, et al.: Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold. Virology 2010;405(2):513-523
    • (2010) Virology , vol.405 , Issue.2 , pp. 513-523
    • Totrov, M.1    Jiang, X.2    Kong, X.P.3
  • 16
    • 0032210842 scopus 로고    scopus 로고
    • Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120
    • Pinter A, Honnen WJ, Kayman SC, Trochev O, and Wu Z: Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120. Vaccine 1998;16(19):1803-1811
    • (1998) Vaccine , vol.16 , Issue.19 , pp. 1803-1811
    • Pinter, A.1    Honnen, W.J.2    Kayman, S.C.3    Trochev, O.4    Wu, Z.5
  • 17
    • 31144451337 scopus 로고    scopus 로고
    • Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants
    • Li Y, Svehla K, Mathy NL, Voss G, Mascola JR, and Wyatt R: Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants. J Virol 2006;80(3):1414-1426
    • (2006) J Virol , vol.80 , Issue.3 , pp. 1414-1426
    • Li, Y.1    Svehla, K.2    Mathy, N.L.3    Voss, G.4    Mascola, J.R.5    Wyatt, R.6
  • 18
    • 77949378988 scopus 로고    scopus 로고
    • In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1
    • Leaman DP, Kinkead H, and Zwick MB: In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1. J Virol 2010;84(7):3382-3395
    • J Virol 2010 , vol.84 , Issue.7 , pp. 3382-3395
    • Leaman, D.P.1    Kinkead, H.2    Zwick, M.B.3
  • 19
    • 0032543307 scopus 로고    scopus 로고
    • Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
    • Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, and Hendrickson WA: Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998;393(6686):648-659
    • (1998) Nature , vol.393 , Issue.6686 , pp. 648-659
    • Kwong, P.D.1    Wyatt, R.2    Robinson, J.3    Sweet, R.W.4    Sodroski, J.5    Hendrickson, W.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.